Lago-Docampo, Mauro http://orcid.org/0000-0002-8799-6079
Tenorio, Jair http://orcid.org/0000-0002-5308-2316
Hernández-González, Ignacio http://orcid.org/0000-0001-7636-9988
Pérez-Olivares, Carmen
Escribano-Subías, Pilar http://orcid.org/0000-0002-6640-4839
Pousada, Guillermo http://orcid.org/0000-0002-2466-8094
Baloira, Adolfo
Arenas, Miguel http://orcid.org/0000-0002-0516-2717
Lapunzina, Pablo http://orcid.org/0000-0002-6324-4825
Valverde, Diana http://orcid.org/0000-0002-7024-1657
Funding for this research was provided by:
Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (PI18/01233)
Actelion Pharmaceuticals
Ministerio de Ciencia, Innovación y Universidades, Gobierno de España (RYC-2015-18241)
Xunta de Galicia (ED431C 2018/54, ED431G-2019/06)
Article History
Received: 17 January 2020
Accepted: 25 August 2020
First Online: 15 September 2020
Competing interests
: The authors declare no competing interests.